Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
D000230:Adenocarcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D010919:Placebos; D013274:Stomach Neoplasms / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D004338:Drug Combinations; D010919:Placebos; D003561:Cytarabine; D005472:Fluorouracil